Adcendo ApSpartnershipAdcendo broadens ADC pipeline in US$1bn bi...Danish ADC maker Adcendo ApS has licenced the rights to commercialise Multitude Therapeutics Inc’s first-in-class ADCE-T02 globally except the Greater China region. more ➔
Stefan Navarro, Experimental Biomedicine I / University Hospital Würzburg, GermanyThrombosisEmfret presents novel anticoagulantGerman biotech spin-out Emfret Analytics GmbH & Co. KG has presented a first in class anticoagulant that helps preventing heart attacks and stroke while showing less adverse effects than approved … more ➔
Medilink TherapeuticsCancerBioNTech: ADC study continues with conditi...Good news for BioNTech SE: The safety study of the ADC BNT326/YL202 developed by MediLink Therapeutics, which was suspended by the FDA in mid-June, will continue. more ➔
Bavarian Nordic A/SEMABavarian Nordic A/S applies for EU label e...Danish vaccine maker Bavarian Nordic A/S has submitted data to the EMA that support label extension of its mpox vaccine imvanex indication to include adolescents 12 to 17 years of age. more ➔
Drug DiscoveryEvotec axes 400 jobs worldwideAfter the drug discovery specialist Evotec SE lowered its annual forecast and lost almost 75% of its market capitalisation in just eight months, the new CEO, Christian Wojczewski, is taking action and … more ➔
Max Planck Institute for Terrestrial Microbiology/GeiselDecarbonisationNitrogenases also can fix CO2Investigating substrate selectivity of nitrogenase enzymes in phototrophic R. capsulatus bacteria, German microbiologist have found one converting CO2 to formiate and methane opening the way to fossil … more ➔
Sphingotec GmbHDiagnosticsSphingotec secures Series C financingGerman diagnostics specialist SphingoTec GmbH has closed a €5m Series C financing round led by Think.Health Ventures. more ➔
AMRNew antibiotic breaks resistanceA Dutch-German resarch team together with Evotec SE have presented a new class of vancomycin derivatives with good safety profile that kill multi-resistant, Gram-positive bugs. more ➔
Sangamo Therapeutics IncpartnershipRoche inks US$2bn biobucks deal with Sanga...After Sangamo Therapeutics Inc. presented an epigenetic ZFN-based repressor at ASGCT 2024 that reduces the expression of the tau protein in the hippocampus by 95% in Alzheimer’s models, Roche’s US subsidiary … more ➔
Carbios SASBioplasticsCarbios SAS to expand PET recycling portfo...French bioplastics recycling specialist Carbios SAS and British recycling and waste management company FCC Environment want to establish a PET biorecycling facility in the UK. more ➔
Adcendo ApS
Stefan Navarro, Experimental Biomedicine I / University Hospital Würzburg, Germany
Medilink Therapeutics
Bavarian Nordic A/S
Max Planck Institute for Terrestrial Microbiology/Geisel
Sphingotec GmbH
Sangamo Therapeutics Inc
Carbios SAS